Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-21
DOI
10.1007/s00262-020-02524-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Doxorubicin and Anti-PD-L1 Antibody Conjugated Gold Nanoparticles for Colorectal Cancer Photochemotherapy
- (2019) Fakhrossadat Emami et al. MOLECULAR PHARMACEUTICS
- PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma
- (2019) Yui Hirata-Nozaki et al. Journal of Translational Medicine
- Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma
- (2019) Shohei Harabuchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- High Vimentin Expression Predicts a Poor Prognosis and Progression in Colorectal Cancer: A Study with Meta-Analysis and TCGA Database
- (2018) Le Du et al. Biomed Research International
- Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma
- (2018) Kenzo Ohara et al. OncoImmunology
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- UniProt: the universal protein knowledgebase
- (2016) NUCLEIC ACIDS RESEARCH
- Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
- (2016) Takumi Kumai et al. Cancer Immunology Research
- High Vimentin Expression Associated with Lymph Node Metastasis and Predicated a Poor Prognosis in Oral Squamous Cell Carcinoma
- (2016) Shuli Liu et al. Scientific Reports
- Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell-Mediated Antitumor Immunity
- (2015) V. A. Brentville et al. CANCER RESEARCH
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma
- (2015) Takumi Kumai et al. Scientific Reports
- Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53
- (2014) Takumi Kumai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy
- (2013) T Kumai et al. BRITISH JOURNAL OF CANCER
- Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer
- (2013) Yuji Toiyama et al. CARCINOGENESIS
- Curcumin Suppresses Doxorubicin-Induced Epithelial–Mesenchymal Transition via the Inhibition of TGF-β and PI3K/AKT Signaling Pathways in Triple-Negative Breast Cancer Cells
- (2013) Wei-Chih Chen et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Cancer Peptide Vaccine Therapy Developed from Oncoantigens Identified through Genome-wide Expression Profile Analysis for Bladder Cancer
- (2012) W. Obara et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
- (2012) Ann G. Zauber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
- (2011) Satoshi Hayashi et al. Journal of Translational Medicine
- Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol
- (2010) Marissa Albert et al. CANCER
- Tumor-reactive CD4+T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
- (2010) Sergio A. Quezada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Vimentin is a novel AKT1 target mediating motility and invasion
- (2010) Q-S Zhu et al. ONCOGENE
- Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy
- (2009) F. R. Depontieu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started